Based on this observation, a detailed analysis of the TP53 mutational status combined with the activity of YAP (the latter not only determined by gene amplification but also by gene expression and protein activity) in relation to stage/grade of the tumor and prognosis of lung cancer patients can be a starting point for future studies headed in this direction. The gene discussed is TP53; the disease is neoplasm.